Sven Ring
26Patents
6h-index
59Co-inventors
72Inventor score
Filing activity: Sep 9, 1994 → Mar 16, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7534780B2 | Estradiol prodrugs | Chemistry; Metallurgy | 56 | Active |
| US6388109B1 | 14,15-cyclopropano steroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds | Human Necessities | 55 | Expired |
| US9951086B2 | Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments | Emerging Cross-Sectional Technologies | 19 | Active |
| US6825182B2 | 17&agr;-fluoroalkyl-11&bgr;-benzaldoxime steroids, process for their production, pharmaceutical preparations that contain these steroids as well as their use for the production of pharmaceutical agents | Chemistry; Metallurgy | 14 | Expired |
| US9951027B2 | Benzimidazol-2-amines as MIDH1 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US9957235B2 | Benzimidazol-2-amines as mIDH1 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US6365582B1 | S-substitute 11&bgr;-benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds | Chemistry; Metallurgy | 4 | Expired |
| US10370339B2 | N-Methylbenzimidazoles as mIDH1 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US5831104A | Steroid intermediate products and method of their production | Chemistry; Metallurgy | 1 | Expired |
| US6710039B1 | Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharamceutical compositions containing these compounds | Human Necessities | 1 | Expired |
| US10414734B2 | 5-hydroxyalkylbenzimidazoles as mIDH1 inhibitors | Human Necessities | 1 | Active |
| US7268241B2 | Method for the production of 4-(17$g(a)-methyl substituted 3-oxoestra-4 9-dien-11$g(b)-yl)benzaldehyd-(1e or 1z)-oximes | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8207150B2 | 17β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative | Chemistry; Metallurgy | 0 | Active |
| US7053229B2 | Process for the production of 4-(17α-alkoxymethyl-17β-substituted 3-oxoestra-4,9-dien-11β-yl) benzaldehyde-(1E)-oxime derivatives | Chemistry; Metallurgy | 0 | Expired |
| US8987239B2 | 19-nor-steroid derivatives with a 15α,16α-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives | Chemistry; Metallurgy | 0 | Active |
| US10442772B2 | Benzimidazol-2-amines as mIDH1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US6723715B1 | 14, 15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds | Human Necessities | 0 | Expired |
| US8937058B2 | 17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivative | Chemistry; Metallurgy | 0 | Active |
| US7388003B2 | Δ15-D-Homosteroids with androgenic action | Human Necessities | 0 | Expired |
| USRE39862E1 | Unsaturated 14, 15-cyclopropanoandrostanes, a method for their production and pharmaceutical compositions containing these compounds | General | 0 | Expired |
| US6534490B1 | Unsaturated 14, 15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds | Human Necessities | 0 | Expired |
| US6794409B2 | Use of ER&bgr;-selective ligands for regulating fertility and compounds useful therefor | Human Necessities | 0 | Expired |
| US8623850B2 | 15, 16-methylene-17-(1′-propenyl)-17,3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative | Human Necessities | 0 | Active |
| US7473709B2 | 11β-benzaldoxime derivatives of D-homooestra-4,9-dien-3-ones | Human Necessities | 0 | Active |
| US7214808B2 | Method for the production of 4-(17α-substituted-3-oxoestra-4,9-dien-11β-yl)benzaldehyde-(1E)-oximes | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.